Home >  Registry
     
 
 Protocol Registry Trial Results IFPMA Background Links
About this Registry

This registry serves as a global repository for information on ongoing Roche Pharmaceuticals Phase II to Phase IV clinical studies, Phase I studies in patients and Roche Diagnostics interventional studies on advanced diagnostic products.

For More Information 

Common Questions
More Frequently Asked Questions 
Overview of Clinical Trials 
Glossary of Terms 
Phase Definitions 
Field Definitions 
Roche Clinical Trial Global Policy 
Site Provided by Thomson CenterWatch

Diabetes Mellitus, Type 2

  • A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
    Recruiting


  • A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
    Recruiting


  • A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise.
    Recruiting


  • A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.
    Recruiting


  • A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.
    Recruiting


  • A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.
    Recruiting


  • A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.
    No longer recruiting


  • A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.
    No longer recruiting


  • A Study of DPP-IV (3) in Patients With Type 2 Diabetes.
    Completed


  • A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
    Completed


  • A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and Class II Heart Failure.
    Completed


  • A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
    Completed


  • A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
    Completed


  • A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus
    Completed


  • A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin
    Completed


  • A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.
    Completed


  • A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
    Completed


  • A Multiple Ascending Dose Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Glimepiride.
    Completed


  • A Study to Evaluate the Effect of GK Activator (2) on QT Interval in Patients With Type 2 Diabetes Mellitus.
    Completed


  • A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.
    Completed


  • A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.
    Completed


  • A Drug-Drug Interaction Study of GK Activator (2) and Ethanol in Patients With Type 2 Diabetes.
    Completed


  • A Study of Aleglitazar in Patients With Type 2 Diabetes
    Completed


  • A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.
    Completed


  • A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
    Completed


  • A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment.
    Terminated


    		•

    © 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement